Search Results - Eda Capkin
- Showing 1 - 5 results of 5
-
1
-
2
-
3
Optimized Methods for Analytical and Functional Comparison of Biosimilar mAb Drugs: A Case Study for Avastin, Mvasi, and Zirabev by Büşra Gürel, Eda Çapkın, Ayhan Parlar, Aylin Özkan, Meltem Çorbacıoğlu, Duygu Emine Dağlikoca, Meral Yüce
Published in Scientia Pharmaceutica (2022-05-01)Get full text
Article -
4
Structural and Functional Analysis of CEX Fractions Collected from a Novel Avastin<sup>®</sup> Biosimilar Candidate and Its Innovator: A Comparative Study by Busra Gurel, Melike Berksoz, Eda Capkin, Ayhan Parlar, Meltem Corbacioglu Pala, Aylin Ozkan, Yılmaz Capan, Duygu Emine Daglikoca, Meral Yuce
Published in Pharmaceutics (2022-07-01)Get full text
Article -
5
Combined crystallographic fragment screening and deep mutational scanning enable discovery of Zika virus NS2B-NS3 protease inhibitors by Xiaomin Ni, R. Blake Richardson, Andre Schutzer Godoy, Matteo P. Ferla, Caroline Kikawa, Jenke Scheen, William W. Hannon, Eda Capkin, Noa Lahav, Blake H. Balcomb, Peter G. Marples, Michael Fairhead, SiYi Wang, Eleanor P. Williams, Charles W. E. Tomlinson, Jasmin C. Aschenbrenner, Ryan M. Lithgo, Max Winokan, Charline Giroud, Isabela Dolci, Rafaela Sachetto Fernandes, Glaucius Oliva, Anu V. Chandran, Mary-Ann Xavier, Martin A. Walsh, Warren Thompson, Jesse D. Bloom, Nathaniel T. Kenton, Alpha A. Lee, Annette von Delft, Haim Barr, Karla Kirkegaard, Lizbé Koekemoer, Daren Fearon, Matthew J. Evans, Frank von Delft
Published in Nature Communications (2025-10-01)Get full text
Article
